Destiny Pharma Limited
6Patents
3Active
6Granted
36Portfolio score
Filing activity: Apr 30, 2001 → Oct 23, 2009 · 3 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6630128B1 | Porphyrin derivatives their use in photodynamic therapy and medical devices containing them | Human Necessities | 28 | Expired |
| US7244841B2 | Porphyrin derivatives and their use in photodynamic therapy | Human Necessities | 13 | Expired |
| US6863693B2 | Phospholipid-coated implants | Human Necessities | 2 | Expired |
| US9326511B2 | Methods of inhibiting microbial biofilms | Emerging Cross-Sectional Technologies | 2 | Active |
| US8084602B2 | Porphyrin derivatives and their use in photodynamic therapy | Human Necessities | 0 | Active |
| US7977474B2 | Uses of porphyrin compounds | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.